[1] CUI Hua,MIAO Dong-mei,WEI Zhi-min,et al.Prevalence of Cardiovascular Disease in Subjects Hospitalized Due to Chronic Obstructive Pulmonary Disease in Beijing from 2000 to 2010 [J].J. Geriatr. Cardiol.,2012,9(1):5-10.[2] ANGELIKI M,TSIMOGIANNI SPYROS A,PAPIRIS GEORGIOS T,et al.Stathopoulos Predictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease [J].J. Gen. Intern. Med.,2009,24(9):1 043-1 048. [3] ZHong Nan-shan,WANG Chen,YAO Wan-zhen,et al.Prevalence of Chronic Obstructive Pulmonary Disease in China:A Large,Population Based Survey [J].Am. J. Respir. Crit. Care Med.,2007,176:753-760.[4] 龚益,时国朝,万欢英,等.上海城区60岁以上人群5年内COPD患病率变化及原因分析 [J].上海交通大学学报:医学版,2011,31(2):216-220.[5] BEDNAREK M,MACIEJEWSKI J,WOANIAK M,et a1.Pmvalence,Severity and Underdiagnosis of COPD in the Primary Care Setting [J].Thorax,2008,63:402-407.[6] 姚婉贞,朱红,沈宁,等.北京市延庆县慢性阻塞性肺疾病流行病学调查结果 [J].北京大学学报:医学版,2005,37(2):121-126.[7] FRITS ME FRANSSEN,MARTIJN A SPRUIT,EMIEL FM WOUTERS.Determinants of Polypharmacy and Compliance with GOLD Guidelines in Patients with Chronic Obstructive Pulmonary Disease [J].Int. J. Chron. Obstruct. Pulmon. Dis.,2011(6):493-501.[8] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南 2007 年修订版 [J].中华结核和呼吸杂志,2007,30(1):8-17.[9] 史亚鹏,黄军军,廖伟华.社区慢性阻塞性肺疾病(COPD)高危人群调查分析及健康管理对策 [J].中国社区医师:医学专业,2011,20(3):201-202.[10] MORISKY D E,ANG A,KROUSE-l WOOD M,et al.Predictive Validity of a Medication Adherence Measure for Hypertension Control [J].Journal of Clinical Hypertension,2008,10(5):348-354.[11] MILGROM H,BENDER B,ACKERSON L,et al.Non-Compliance and Treatment Failure in Children with Asthma [J].J. Allergy & Clinical Immunology,1996,98(6):1 051-1 057.[12] 赵红霞,范秋霞.慢性阻塞性肺疾病病人用药依从性影响因素分析 [J].护理研究,2010(5):1 247-1 248.[13] 薛培丽,曾凤英.支气管哮喘患者吸入激素治疗依从性分析 [J].现代预防医学,2007,34(15):2 970-2 971.[14] 李绍珍.哮喘吸入激素治疗中相关问题与临床对策的综述 [J].职业与健康,2003,19(9):134-135. |